Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

Pamela M J McLaughlinMaximilian KlarTibor A ZwimpferGilles DutilhMarcus VetterChristian MarthAndreas du BoisCarmen Schade-BrittingerAlexander ReussClaudine BommerChristian KurzederViola A Heinzelmann-Schwarz

Published in: BMC cancer (2022)

This trial is registered at clinicaltrials.gov under the identifier NCT04111978 . Registered 02 October 2019.

Keyphrases

phase iii
placebo controlled
open label
study protocol
double blind
clinical trial
phase ii
randomized controlled trial
phase ii study
stem cells
squamous cell carcinoma
mesenchymal stem cells